You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Arabic
Home
Currently selected
About us
Who We Are
KAIMRC Strategic Goals
Who We Are
LETTERS
A Letter from the CEO
A Letter from the Executive Director
Leadership & Management Team
Contact us
Executive Director
Enterprise Structure
Administraion
Executive Office
Operation
Research Quality Management
Strategy and Business Development
DEPARTMENTS AND PROGRAMS
Saudi Biobank Center
Experimental Medicine Research
Medical Genomics Research
Medical Research Core Facilities & Platforms
Developmental Medicine
Population Health Research
Trauma Research Program
Infectious Disease Research
Vaccine Development Unit
Blood and Cancer Research
Cord Blood Bank
Saudi Stem Cells Donor Registry
Nanomedicine Research
Immunology Research Program
AI and bioinformatics
SUPPORT SERVICES
Research Office
Institutional Review Board
Institutional Animal Care and Use Committee
Bioethics
Clinical Trial Management
Research Performance and Outcome Department (RPO)
KAIMRC Research Academy
Innovation and Entrepreneurship Department
Medical Biotechnology Park
Pharmaceutical Analysis Center
Advanced Computing and Technologies
Biostatistics
WESTERN REGION
EASTERN REGION
E-Services
Research Proposal Submission System
Research Data Request Form
Clinical Trial Community Members Registry
Medical Genomic Research Services
Medical Research Core Facilities and Platforms Services
Job Application
Transfer/Promotion Portal
Complaints Form
AI and Bioinformatics Services
Media & Communication
Publications Books
2022
part 1
part 2
2021
Part 1
Part 2
2020
2019
2018
2017
2016
2015
2014
Innovation Magazines
December 2019
December 2020
December 2021
June 2019
June 2020
June 2021
Newsletters
April 2017
December 2015
December 2018
December 2019
January 2017
July 2016
July 2019
July 2020
June 2021
March 2019
October 2016
October 2020
October 2021
Conference Reports
10th Annual Forum Report 2019
11th Annual Forum Report 2020
1st Therapeutics Discovery Conference Report 2017
2nd Therapeutics Discovery Conference Report 2020
9th Annual Forum Report 2018
Riyadh Global Medical Biotechnology Summit RGMBS 2021
Brochure
Events Calendar
Team Photo Gallary
Dictionary of Digital Government Authority
KAIMRC Research Portal
Scientists' Google Scholar Profiles
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Arabic
Saudi Biobank Project
Page Image
Page Content
The goal of the Saudi Biobank is to increase the quality of patient care and accelerate the impact of research on such care. It will implement the highest standards of biological banking to provide outstanding clinical, medical, demographical, and analytical data. The Saudi Biobank is designed as a longitudinal investigation of demographical and environmental factors influencing illnesses in Saudi Arabia. The Saudi Biobank’s objective is to implement the highest standards of biological banking as it is vital for building genomic/proteomics databases. These databases will increase the quality of healthcare by creating a link between lifestyle, environment, and clinical practice. The biological samples at the Saudi Biobank will include buffy coat, serum, urine and tissues. The Saudi Bio-bank team is targeting 200,000 individuals and diseased subjects for fluid and solid body tissue samples, while DNA/RNA reservoir capacity is 1.8 million matrix tubes for genetic diseases seen in day-to-day clinical practice. The Saudi Biobank has launched a complete automated DNA banking system that carries out a full robotic extraction of DNA from blood, followed by banking the samples at -20˚C. The retrieval of the samples is also auto-programmed by the LIMS system.